Abstract

Aim: the aim of our study was to investigate the association of insulin-like growth factor-1 and its binding protein 3 levels with CRC risk factors and symptoms by multiple regression analyzes. Methods: The IGF-1 laboratory test was performed using the ECLIA method. Serum insulin and glucose levels were assessed by oral glucose tolerance test (OGTT) in fasting state and after 120 minutes of glucose loading (40 g / 1 m2 of body surface). Multiple regression analysis performed to study the mutual impact of different parameters on outcome (IGF-1 and IGF BP3). Results: Finally, significant variables (factors) were left in the model having mutual effect on the outcome (IGF BP3 value). The linear multiple regression function took the following form: Hence these factors (each factor in parentheses indicates the nature of the correlation - direct or inverse): X1 - Sex (direct); X4 – Code of Surgery (inverse); X7 – other general pains/symptoms (inverse); X13 - Flatulence Gases (inverse); X14 - Diarrhea (direct); X20 – A course of chemotherapy or radiation therapy before surgery (inverse); X27 – HOMA-S (direct); X28 - HOMA-IR (inverse); X31 – creatinine (direct). Conclusion: Based on the results of current study we concluded that CRC is multifactorial and many significant factors are responsible for its development. One of possible mechanisms for its development is the changes insulin/IGF-1 signaling pathway with other significant biological and non-biological factors.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.